Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database
MA Barbieri, PM Cutroneo, C Baratelli… - Journal of Clinical …, 2021 - Wiley Online Library
Abstract Objective Direct oral anticoagulants (DOACs) were developed to avoid the
limitations of vitamin K antagonists (VKAs). DOACs are associated with a greater incidence …
limitations of vitamin K antagonists (VKAs). DOACs are associated with a greater incidence …
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database
MA Barbieri, PM Cutroneo… - Journal of clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Objective Direct oral anticoagulants (DOACs) were developed to avoid the limitations of
vitamin K antagonists (VKAs). DOACs are associated with a greater incidence of …
vitamin K antagonists (VKAs). DOACs are associated with a greater incidence of …
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database.
MA Barbieri, PM Cutroneo, C Baratelli… - Journal of Clinical …, 2021 - search.ebscohost.com
Abstract Objective: Direct oral anticoagulants (DOACs) were developed to avoid the
limitations of vitamin K antagonists (VKAs). DOACs are associated with a greater incidence …
limitations of vitamin K antagonists (VKAs). DOACs are associated with a greater incidence …
[引用][C] Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database
MA Barbieri, C Baratelli, E Spina, M Bungaro… - Journal of Clinical …, 2021 - Elsevier
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database
MA Barbieri, PM Cutroneo, C Baratelli… - JOURNAL OF …, 2021 - iris.unime.it
Abstract Objective: Direct oral anticoagulants (DOACs) were developed to avoid the limita-
tions of vitamin K antagonists (VKAs). DOACs are associated with a greater incidence of …
tions of vitamin K antagonists (VKAs). DOACs are associated with a greater incidence of …
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database.
MA Barbieri, PM Cutroneo, C Baratelli… - Journal of Clinical …, 2021 - europepmc.org
Objective Direct oral anticoagulants (DOACs) were developed to avoid the limitations of
vitamin K antagonists (VKAs). DOACs are associated with a greater incidence of …
vitamin K antagonists (VKAs). DOACs are associated with a greater incidence of …